Evidence mapPaperPMID 41517846Full record

ReviewJournal of gastric cancer2026

The Changing Landscape of Hereditary Diffuse Gastric Cancer.

Conor Vaessen, Kieran Redpath, Emily Schulpen, Parry Guilford

Abstract readReview
In one paragraph

Review in Journal of gastric cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Conor Vaessen *Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Kieran Redpath *Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand.ORCID 0000-0002-2221-7038
Emily SchulpenCancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand.ORCID 0009-0009-5514-2907
Parry GuilfordCancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand. parry.guilford@otago.ac.nz.ORCID 0000-0002-7256-9576

Funding

New Zealand Health Research Council 22/301No Stomach for CancerSave Our Stomachs
6 · The paper itself

Abstract

Hereditary diffuse gastric cancer (HDGC) is a dominantly inherited cancer syndrome characterized by the early onset of diffuse gastric cancer (DGC) and lobular breast cancer. HDGC is predominantly caused by germline truncating mutations in

Indexed as

Neoplastic Syndromes, HereditaryStomach Neoplasmsalpha CateninAntigens, CDCadherinsGastrectomyGenetic Predisposition to DiseaseGerm-Line MutationHumansalpha CateninAntigens, CDCadherinsCDH1 protein, humanCTNNA1 protein, humanCadherinsCateninsGastrectomyNeoplastic syndromesSignet ring cell carcinoma

Identifiers

PMID41517846
PMCPMC12802062

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.